Riskpilot← Back to searchSign inGet full accessChammout hälsovård AB
ABActiveOrg 5568600802Stormgränd 1General medical practice activities · NACE 8621Est. 20111-4 employees
Revenue 2025
SEK 4,2M
-12% vs 2024
EBITDA margin
66.6%
-23% vs 2024
Equity ratio
71.1%
Financial strength
Net profit 2025
SEK 2,2M
-4% vs 2024
| Revenue | SEK 4,2M | -12% |
| EBITDA | SEK 2,8M | -23% |
| Net profit | SEK 2,2M | -4% |
| Total assets | SEK 17,2M | +14% |
| Equity | SEK 12,2M | +23% |
| Employees | — | — |
Legal name
Chammout hälsovård AB
Org number
5568600802
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
27 juli 2011
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Chammout, Ghazi
Company purpose
Hälsovårdens tjänster.
Address
Stormgränd 1
Email
ghazichammout@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 013 | 3 091 | 4 102 | 4 800 | 4 211 |
| Staff expenses | — | −825 | −979 | −1 041 | −1 277 |
| EBITDA | 3 341 | 2 091 | 2 955 | 3 639 | 2 804 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 3 341 | 2 091 | 2 955 | 3 639 | 2 804 |
| Net financials | — | −162 | −68 | 226 | 599 |
| Profit before tax | 2 541 | 1 418 | 2 923 | 2 971 | 2 885 |
| Tax | −546 | −329 | −636 | −625 | −636 |
| Net profit | 1 995 | 1 090 | 2 287 | 2 346 | 2 249 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 10 103 | 10 980 | 12 136 | 15 045 | 17 191 |
| Equity | 5 859 | 6 942 | 7 830 | 9 975 | 12 225 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 1 546 | 828 | 1 134 | 1 002 | 380 |
| Total debt | 1 546 | 828 | 1 134 | 1 002 | 380 |
EBITDA margin
66.6%
This company
15.8%
Market median
+322% vs market
20212025
Equity ratio
71.1%
This company
38.2%
Market median
+86% vs market
20212025
Return on equity
18.4%
This company
18.4%
Market median
+0% vs market
20212025
Net profit margin
53.4%
This company
8.1%
Market median
+559% vs market
20212025
Asset turnover
0.24×
This company
1.12×
Market median
-79% vs market
20212025
Debt / equity
0.41×
This company
0.62×
Market median
+34% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
GC Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Chammout hälsovård AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ghazi Chammout | Chief Executive Officer | 0 companies |
| Yilmaz Demir | Deputy Board Member | 0 companies |
| Antony Chammout | Deputy Board Member | 0 companies |